The impact of dysphagia in Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel

The impact of dysphagia in Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel
Parkinsonism Relat Disord. 2023 Mar 15;109:105368. doi: 10.1016/j.parkreldis.2023.105368. Online ahead of print.ABSTRACTBACKGROUND: Dysphagia is common in advanced phases of Parkinson disease (PD), and is a risk factor for aspiration pneumonia. Nonetheless, dysphagia has been poorly investigated in PD patients treated with levodopa-carbidopa intestinal gel (LCIG). We aimed to analyze the impact of dysphagia on mortality in LCIG treated patients and ... read more
Source: PubMedPublished on 2023-03-18By Domiziana Rinaldi